Hologic awarded $4.8 million in patent infringement lawsuit
Hologic has won a patent infringement case against Minerva Surgical for infringing on two patents related to endometrial ablation technology.
Hologic brought the suit against Minerva in 2015 in the US District Court for the District of Delaware alleging that Minerva’s endometrial ablation system infringes several Hologic patents.
The patents cover technology in NovaSure endometrial ablation procedures, which is used to treat abnormal uterine bleeding.
Former executive founded Minerva four years after Hologic received its patents, and then developed and commercialized the technology.
Hologic was awarded $4.8 million in damages, and it will now seek an injunction prohibiting Minerva from further manufacturing or selling the infringing device in the US. The awarded damages will also continue to accrue until Minerva ceases its infringing conduct.
Commenting on the ruling, president of GYN Surgical Solutions at Hologic Sean Daugherty, said: “We are extremely pleased with the Court’s ruling and the jury’s verdict, which together validates Hologic’s assertions of patent infringement by Minerva Surgical and recognizes the value of our intellectual property.”
“As the maker of the NovaSure system, we are committed to delivering best-in-class products backed by strong clinical data for our customers and their patients.”